Published: Aug. 5, 2019, 3 a.m.
Professor Serhan expands on the application of SPMs inside the inflammation-resolution cycle and outside this cycle, highlighting alternative mechanisms, the wide scope of SPM therapy and exciting new treatment considerations currently within the field of lipid research.
\n\n
\n- Prof Serhan background on moving into studying lipid mediators. (1:30)
\n- Aspirin triggers biosynthesis of lipid mediators. (4:57)
\n- Old to new: Review of inflammation and stimulating resolution processes. (6:55)
\n- Resolvins reduce neutrophilic infiltration and inducing \u201cself-limitation\u201d. (11:14)
\n- Plasticity of macrophage poles \u2013 key function of SPMs. (13:48)
\n- Healthy human breast milk contains SPMs. (19:45)
\n- Structures, receptors and functional location of Resolvins. (20:44)
\n- Downregulation of biosynthetic enzymes and using SPMs. (25:00)
\n- Aged mice with enhanced inflammatory response and diminished resolution response. (29:00)
\n- SPMs in obesity models. (31:00)
\n- Role of SPMs in additional chronic inflammatory conditions. (40:05)
\n- SPM killing and clearance of infections without immune suppression. (44:34)
\n- SPMs, macrophage types and tumor reduction. (46:45)
\n- Topical SPM application in animal models. (49:51)
\n- Future publication on periodontal disease. (52:53)
\n